Pro-Dex (PDEX) Stock Price, News & Analysis

Company Overview

Pro-Dex, Inc. is a medical device company that designs, develops and manufactures powered surgical instruments and related equipment. Its products are primarily used in orthopedic, dental and other surgical procedures, where precision, reliability and controlled power are important.

The company supplies instruments and components to original equipment manufacturers and other medical device customers. Its capabilities include product design and development, engineering, manufacturing, assembly and related support services. Pro-Dex’s offerings include powered handpieces, drive systems and associated electronic or mechanical components used in specialized surgical applications.

Pro-Dex is headquartered in Irvine, California, and serves customers in the medical device industry in the United States and international markets. The company operates primarily as a business-to-business manufacturer, with its products generally incorporated into or marketed through customers’ medical device platforms and product lines.

Key Stats

• Today's Range: $63.45 to $67.00
• 50-Day Range: $54.88 to $73.41
• 52-Week Range: $23.47 to $77.00
• Volume: 43,753 shs
• Average Volume: 51,943 shs
• Market Capitalization: $209.28 million
• P/E Ratio: 15.84
• Dividend Yield: N/A
• Price Target: $74.00
• Consensus Rating: Buy

Pro-Dex Stock Analysis - MarketRank™

Pro-Dex scored higher than 71% of companies evaluated by MarketBeat, and ranked 156th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Buy

Consensus Rating

Pro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

Pro-Dex has a consensus price target of $74.00, representing about 13.1% upside from its current price of $65.40.

Amount of Analyst Coverage

Pro-Dex has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.74%

Earnings Growth

Earnings for Pro-Dex are expected to grow by 8.74% in the coming year, from $3.09 to $3.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Pro-Dex is 15.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of Pro-Dex is 15.84, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.64.

Price to Book Value per Share Ratio

Pro-Dex has a P/B Ratio of 4.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.11% of the float of Pro-Dex has been sold short.

Short Interest Ratio / Days to Cover

Pro-Dex has a short interest ratio ("days to cover") of 2.29, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Pro-Dex has recently increased by 17.40%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Pro-Dex does not currently pay a dividend.

Dividend Growth

Pro-Dex does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Pro-Dex has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Healthcare companies.

Search Interest

5 people have searched for PDEX on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,351,657.00 in company stock.

Percentage Held by Insiders

45.90% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

15.28% of the stock of Pro-Dex is held by institutions.

Company Calendar

• Last Earnings: 9/03/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:PDEX
• CIK: 788920
• Web: www.pro-dex.com
• Phone: (949) 769-3200
• Fax: 949-769-3281
• Employees: 206
• Year Founded: 1975

Price Target and Rating

• Average Price Target for Pro-Dex: $74.00
• High Price Target: $74.00
• Low Price Target: $74.00
• Potential Upside/Downside: +13.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.13
• Trailing P/E Ratio: 15.84
• Forward P/E Ratio: 21.17
• P/E Growth: N/A
• Net Income: $13.66 million
• Net Margins: 17.62%
• Pretax Margin: 23.23%
• Return on Equity: 25.13%
• Return on Assets: 16.02%

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 4.10
• Quick Ratio: 2.45

Sales & Book Value

• Annual Sales: $77.55 million
• Price / Sales: 2.70
• Cash Flow: $3.98 per share
• Price / Cash Flow: 16.42
• Book Value: $14.92 per share
• Price / Book: 4.38

Miscellaneous

• Outstanding Shares: 3,200,000
• Free Float: 1,733,000
• Market Cap: $209.28 million
• Optionable: Not Optionable
• Beta: 0.04